Background/aims The antiseizure medication, vigabatrin, is associated with visual field loss (VAVFL). However, the fields can be challenging to interpret due to unfamiliarity with the characteristics ...
Background/aims Data on morphological characteristics and outcomes of extremely short eyes undergoing cataract surgery is sparse. Thus, an in-depth characterisation of eyes implanted with a high-power ...
Purpose To compare the structure-function correlations between optical coherence tomography (OCT) thickness parameters and the corresponding sectorial mean sensitivity (MS) values obtained with IMO ...
Aims To investigate whether industry-sponsored randomised control trials (RCT) on myopia control have more favourable outcomes and differ in risk of bias, compared with studies having other sources of ...
a Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, Netherlands, b Department of Endocrinology, Academic Medical Center, University of Amsterdam, ...
4 Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne Correspondence to: David A Mackey, CERA, Royal Victorian Eye and Ear Hospital, 32 Gisborne Street, East Melbourne, ...
Background/aim: Intraocular pressure (IOP) is not a fixed constant value but rather has pulsatile components associated with cardiac action. The SmartLens dynamic observing tonometer (odc, Ophthalmic ...
Primary congenital glaucoma is a rare disease but has a major impact on the child’s development and quality of life over his/her whole life span. Early diagnosis and appropriate therapy can make a ...
Department of Vitreo-Retinal Surgery, University of Cologne, Center of Ophthalmology, Cologne, Germany Correspondence to Dr med Albert Caramoy, University of Cologne, Center of Ophthalmology, ...
Institute of Ophthalmology, University College London, 11-43 Bath Street, London EC1V 9EL, UK Correspondence to: Professor Anthony T Moore Institute of Ophthalmology, University College London, 11-43 ...
Inherited retinal diseases (IRDs) have been in the front line of gene therapy development for the last decade, providing a useful platform to test novel therapeutic approaches. More than 40 clinical ...